<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Healthcare Provider Recommender System | Anu P Kumar</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Crimson+Pro:wght@400;600&family=JetBrains+Mono:wght@400;500&display=swap" rel="stylesheet">
    <style>
        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: 'Crimson Pro', serif;
            background: #ffffff;
            color: #000000;
            line-height: 1.6;
            padding: 40px 20px;
        }

        .container {
            max-width: 900px;
            margin: 0 auto;
        }

        .back-link {
            display: inline-block;
            color: #000000;
            text-decoration: none;
            margin-bottom: 40px;
            font-size: 16px;
            border: 1px solid #000000;
            padding: 8px 16px;
            transition: all 0.2s;
        }

        .back-link:hover {
            background: #000000;
            color: #ffffff;
        }

        h1 {
            font-size: 32px;
            font-weight: 600;
            margin-bottom: 10px;
            line-height: 1.3;
        }

        .status {
            color: #2563eb;
            font-family: 'JetBrains Mono', monospace;
            font-size: 0.6em;
            font-weight: 500;
            margin-left: 12px;
        }

        .subtitle {
            font-size: 18px;
            color: #666666;
            margin-bottom: 40px;
        }

        .section {
            margin-bottom: 50px;
        }

        h2 {
            font-size: 24px;
            font-weight: 600;
            margin-bottom: 20px;
            padding-bottom: 8px;
            border-bottom: 1px solid #e5e5e5;
        }

        h3 {
            font-size: 20px;
            font-weight: 600;
            margin: 30px 0 15px 0;
        }

        p {
            margin-bottom: 15px;
            font-size: 18px;
        }

        .tags {
            display: flex;
            flex-wrap: wrap;
            gap: 8px;
            margin-top: 20px;
        }

        .tag {
            font-family: 'JetBrains Mono', monospace;
            font-size: 12px;
            padding: 6px 12px;
            background: #f5f5f5;
            border: 1px solid #e5e5e5;
            color: #000000;
            white-space: nowrap;
        }

        .architecture-diagram {
            margin: 30px 0;
            padding: 20px;
            border: 1px solid #e5e5e5;
        }

        .metrics {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 20px;
            margin: 30px 0;
        }

        .metric-card {
            border: 1px solid #e5e5e5;
            padding: 20px;
        }

        .metric-value {
            font-family: 'JetBrains Mono', monospace;
            font-size: 28px;
            font-weight: 600;
            margin-bottom: 5px;
        }

        .metric-label {
            font-size: 14px;
            color: #666666;
        }

        ul {
            margin-left: 20px;
            margin-bottom: 15px;
        }

        li {
            margin-bottom: 8px;
            font-size: 18px;
        }

        .methodology-steps {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(200px, 1fr));
            gap: 20px;
            margin: 30px 0;
        }

        .step-card {
            border: 1px solid #e5e5e5;
            padding: 20px;
        }

        .step-number {
            font-family: 'JetBrains Mono', monospace;
            font-size: 24px;
            font-weight: 600;
            margin-bottom: 10px;
        }

        .step-title {
            font-weight: 600;
            margin-bottom: 8px;
        }

        .step-description {
            font-size: 16px;
            color: #666666;
        }

        .feature-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(180px, 1fr));
            gap: 12px;
            margin: 20px 0;
        }

        .feature-item {
            border: 1px solid #e5e5e5;
            padding: 12px;
            font-size: 16px;
            text-align: center;
        }

        @media (max-width: 768px) {
            body {
                padding: 20px 15px;
            }

            h1 {
                font-size: 26px;
            }

            .subtitle {
                font-size: 16px;
            }

            .methodology-steps {
                grid-template-columns: 1fr;
            }

            .metrics {
                grid-template-columns: 1fr;
            }

            .feature-grid {
                grid-template-columns: 1fr;
            }
        }
    </style>
</head>
<body>
    <div class="container">
        <a href="index.html" class="back-link">‚Üê Back to Portfolio</a>

        <h1>Propensity-Based HCP Recommender System </h1>
        <p class="subtitle">Commercial Operations | Neuropsychiatric Drug Adoption</p>


        <div class="tags">
            <span class="tag">Propensity Modeling</span>
            <span class="tag">Recommender Systems</span>
            <span class="tag">Gradient Boosting</span>
            <span class="tag">XGBoost</span>
            <span class="tag">LightGBM</span>
            <span class="tag">Feature Engineering</span>
            <span class="tag">Dual Model Training</span>
            <span class="tag">Feature Importance</span>
            <span class="tag">Feature Intersection</span>
            <span class="tag">SHAP</span>
            <span class="tag">Model Explainability</span>
            <span class="tag">A/B Testing</span>
            <span class="tag">Out-of-Time Validation</span>
            <span class="tag">Backtesting</span>
            <span class="tag">IQVIA SOB</span>
            <span class="tag">IQVIA LAAD</span>
            <span class="tag">Healthcare Analytics</span>
            <span class="tag">HCP Targeting</span>
            <span class="tag">Commercial Operations</span>
            <span class="tag">Pharma Analytics</span>
            <span class="tag">Python</span>
            <span class="tag">scikit-learn</span>
        </div>

        <div class="section">
            <h2>Problem</h2>
            <p>Commercial teams lacked data-driven methods to prioritize healthcare provider (HCP) outreach, resulting in inefficient resource allocation and suboptimal targeting strategies. Manual targeting approaches failed to identify high-potential HCPs likely to prescribe neuropsychiatric medications to new patients.</p>
        </div>

        <div class="section">
            <h2>Solution</h2>
            <p>Built a gradient-boosted propensity scoring recommender system to identify and rank HCPs most likely to initiate new patients on neuropsychiatric medications. The system integrates prescription behavior, patient demographics, and treatment patterns from commercial data sources to generate actionable HCP recommendations for field teams.</p>
        </div>

        <div class="section">
            <h2>Methodology</h2>
            
            <div class="methodology-steps">
                <div class="step-card">
                    <div class="step-number">01</div>
                    <div class="step-title">Hypothesis Generation</div>
                    <div class="step-description">Collaborated with Sales & Marketing to identify 6 key constructs predicting HCP prescribing behavior</div>
                </div>
                <div class="step-card">
                    <div class="step-number">02</div>
                    <div class="step-title">Feature Engineering</div>
                    <div class="step-description">Integrated IQVIA SOB and LAAD data to create HCP-level behavioral features</div>
                </div>
                <div class="step-card">
                    <div class="step-number">03</div>
                    <div class="step-title">Model Development</div>
                    <div class="step-description">Dual model training with feature intersection analysis across 50+ iterations</div>
                </div>
                <div class="step-card">
                    <div class="step-number">04</div>
                    <div class="step-title">Deployment</div>
                    <div class="step-description">Generated propensity scores for field targeting and validated via A/B testing</div>
                </div>
            </div>

            <h3>Key Constructs</h3>
            <div class="feature-grid">
                <div class="feature-item">HCP Characteristics</div>
                <div class="feature-item">Prescription Behavior</div>
                <div class="feature-item">Patient Mix</div>
                <div class="feature-item">Market Access</div>
                <div class="feature-item">Engagement Patterns</div>
                <div class="feature-item">Approach to Treatment</div>
            </div>

            <h3>Feature Selection Strategy</h3>
            <p>To ensure model robustness and minimize overfitting, implemented a dual model training approach:</p>
            <ul>
                <li>Trained two independent gradient boosting models on different data splits</li>
                <li>Extracted feature importance rankings from both models</li>
                <li>Selected only features appearing in top rankings across both models (intersection analysis)</li>
                <li>Validated feature stability across 50+ model iterations</li>
                <li>Achieved ~90% overlap in top 10 features, ~80% in top 20, and ~75% in top 50</li>
            </ul>
        </div>

        <div class="section">
            <h2>Architecture</h2>
            <div class="architecture-diagram">
                <svg viewBox="0 0 1000 500" xmlns="http://www.w3.org/2000/svg">
                    <!-- Data Sources -->
                    <rect x="20" y="50" width="180" height="80" fill="none" stroke="black" stroke-width="2"/>
                    <text x="110" y="85" font-family="Crimson Pro" font-size="14" font-weight="600" text-anchor="middle">Data Sources</text>
                    <line x1="20" y1="95" x2="200" y2="95" stroke="black" stroke-width="1"/>
                    <text x="110" y="115" font-family="Crimson Pro" font-size="12" text-anchor="middle">IQVIA SOB</text>
                    <text x="110" y="130" font-family="Crimson Pro" font-size="12" text-anchor="middle">IQVIA LAAD</text>
                    
                    <!-- Arrow 1 -->
                    <line x1="200" y1="90" x2="240" y2="90" stroke="black" stroke-width="2" marker-end="url(#arrowhead)"/>
                    
                    <!-- Feature Engineering -->
                    <rect x="240" y="50" width="180" height="80" fill="none" stroke="black" stroke-width="2"/>
                    <text x="330" y="85" font-family="Crimson Pro" font-size="14" font-weight="600" text-anchor="middle">Feature Engineering</text>
                    <line x1="240" y1="95" x2="420" y2="95" stroke="black" stroke-width="1"/>
                    <text x="330" y="115" font-family="Crimson Pro" font-size="12" text-anchor="middle">6 Key Constructs</text>
                    
                    <!-- Arrow 2 -->
                    <line x1="420" y1="90" x2="460" y2="90" stroke="black" stroke-width="2" marker-end="url(#arrowhead)"/>
                    
                    <!-- Dual Model Training -->
                    <rect x="460" y="20" width="180" height="60" fill="none" stroke="black" stroke-width="2"/>
                    <text x="550" y="45" font-family="Crimson Pro" font-size="14" font-weight="600" text-anchor="middle">Model A</text>
                    <text x="550" y="65" font-family="Crimson Pro" font-size="12" text-anchor="middle">Gradient Boosting</text>
                    
                    <rect x="460" y="100" width="180" height="60" fill="none" stroke="black" stroke-width="2"/>
                    <text x="550" y="125" font-family="Crimson Pro" font-size="14" font-weight="600" text-anchor="middle">Model B</text>
                    <text x="550" y="145" font-family="Crimson Pro" font-size="12" text-anchor="middle">Gradient Boosting</text>
                    
                    <!-- Convergence lines -->
                    <line x1="640" y1="50" x2="680" y2="90" stroke="black" stroke-width="2"/>
                    <line x1="640" y1="130" x2="680" y2="90" stroke="black" stroke-width="2"/>
                    
                    <!-- Feature Intersection -->
                    <rect x="680" y="50" width="140" height="80" fill="none" stroke="black" stroke-width="2"/>
                    <text x="750" y="80" font-family="Crimson Pro" font-size="14" font-weight="600" text-anchor="middle">Feature</text>
                    <text x="750" y="100" font-family="Crimson Pro" font-size="14" font-weight="600" text-anchor="middle">Intersection</text>
                    <line x1="680" y1="95" x2="820" y2="95" stroke="black" stroke-width="1"/>
                    <text x="750" y="115" font-family="Crimson Pro" font-size="11" text-anchor="middle">50+ Iterations</text>
                    
                    <!-- Arrow 3 -->
                    <line x1="750" y1="130" x2="750" y2="180" stroke="black" stroke-width="2" marker-end="url(#arrowhead)"/>
                    
                    <!-- Final Model -->
                    <rect x="670" y="180" width="160" height="100" fill="none" stroke="black" stroke-width="2"/>
                    <text x="750" y="210" font-family="Crimson Pro" font-size="14" font-weight="600" text-anchor="middle">Final Model</text>
                    <line x1="670" y1="220" x2="830" y2="220" stroke="black" stroke-width="1"/>
                    <text x="750" y="240" font-family="Crimson Pro" font-size="12" text-anchor="middle">Propensity Scores</text>
                    <text x="750" y="260" font-family="Crimson Pro" font-size="12" text-anchor="middle">SHAP Analysis</text>
                    
                    <!-- Arrow 4 -->
                    <line x1="750" y1="280" x2="750" y2="320" stroke="black" stroke-width="2" marker-end="url(#arrowhead)"/>
                    
                    <!-- Validation -->
                    <rect x="670" y="320" width="160" height="100" fill="none" stroke="black" stroke-width="2"/>
                    <text x="750" y="350" font-family="Crimson Pro" font-size="14" font-weight="600" text-anchor="middle">Validation</text>
                    <line x1="670" y1="360" x2="830" y2="360" stroke="black" stroke-width="1"/>
                    <text x="750" y="380" font-family="Crimson Pro" font-size="12" text-anchor="middle">Out-of-Time Testing</text>
                    <text x="750" y="400" font-family="Crimson Pro" font-size="12" text-anchor="middle">A/B Testing</text>
                    
                    <!-- Output box -->
                    <rect x="20" y="220" width="180" height="200" fill="none" stroke="black" stroke-width="2"/>
                    <text x="110" y="250" font-family="Crimson Pro" font-size="14" font-weight="600" text-anchor="middle">Representative</text>
                    <text x="110" y="270" font-family="Crimson Pro" font-size="14" font-weight="600" text-anchor="middle">Top Drivers</text>
                    <line x1="20" y1="280" x2="200" y2="280" stroke="black" stroke-width="1"/>
                    <text x="110" y="300" font-family="Crimson Pro" font-size="11" text-anchor="middle">HCP Specialty</text>
                    <text x="110" y="318" font-family="Crimson Pro" font-size="11" text-anchor="middle">Adopter Status</text>
                    <text x="110" y="336" font-family="Crimson Pro" font-size="11" text-anchor="middle">Patient Switching</text>
                    <text x="110" y="354" font-family="Crimson Pro" font-size="11" text-anchor="middle">Prescription Share</text>
                    <text x="110" y="372" font-family="Crimson Pro" font-size="11" text-anchor="middle">Payer Mix</text>
                    <text x="110" y="390" font-family="Crimson Pro" font-size="11" text-anchor="middle">Patient Demographics</text>
                    <text x="110" y="408" font-family="Crimson Pro" font-size="11" text-anchor="middle">Treatment Patterns</text>
                    
                    <!-- Arrow marker definition -->
                    <defs>
                        <marker id="arrowhead" markerWidth="10" markerHeight="10" refX="9" refY="3" orient="auto">
                            <polygon points="0 0, 10 3, 0 6" fill="black"/>
                        </marker>
                    </defs>
                </svg>
            </div>
        </div>

        <div class="section">
            <h2>Implementation</h2>
            
            <h3>Data Integration</h3>
            <p>Integrated prescription dispensing data (IQVIA SOB) with claims-level patient data (IQVIA LAAD) to construct comprehensive HCP behavioral profiles. Feature engineering translated domain hypotheses into quantitative signals across prescription patterns, patient demographics, treatment approaches, and market access characteristics.</p>

            <h3>Model Development</h3>
            <p>Implemented gradient boosting (XGBoost/LightGBM) with a dual model training strategy to ensure robust feature selection. Trained two independent models on different data partitions, then selected features appearing in top importance rankings across both models. This intersection approach minimized overfitting and improved generalization to unseen HCPs.</p>

            <h3>Explainability</h3>
            <p>Applied SHAP (SHapley Additive exPlanations) analysis to generate individual HCP-level explanations for both high-propensity and low-propensity prescribers. These explanations enabled commercial teams to understand which behavioral patterns drove model predictions and identify hidden opportunities where low-scoring HCPs converted despite model predictions.</p>

            <h3>Validation Framework</h3>
            <p><strong>Out-of-Time Backtesting:</strong> Validated model performance by training on historical periods and testing on future held-out periods the model had not seen. This temporal validation ensured the model could accurately predict HCP behavior in prospective deployment scenarios.</p>
            <p><strong>Prospective A/B Testing:</strong> Field validation methodology under development to measure real-world impact of model-driven targeting versus standard approaches.</p>
        </div>

        <div class="section">
            <h2>Results</h2>
            <div class="metrics">
                <div class="metric-card">
                    <div class="metric-value">0.77</div>
                    <div class="metric-label">PR-AUC</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">5-7%</div>
                    <div class="metric-label">Conversion Rate Lift</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">50+</div>
                    <div class="metric-label">Model Iterations</div>
                </div>
                <div class="metric-card">
                    <div class="metric-value">~90%</div>
                    <div class="metric-label">Top 10 Feature Overlap</div>
                </div>
            </div>

            <p>The recommender system achieved strong precision-recall performance (0.77 PR-AUC) and demonstrated 5-7% lift in HCP conversion rates compared to baseline targeting approaches. Feature stability analysis across iterations showed ~90% consistency in top 10 drivers, ~80% in top 20, and ~75% in top 50, validating the robustness of the dual model selection strategy.</p>

            <p>SHAP analysis revealed interpretable patterns: high-propensity HCPs exhibited specific combinations of specialty type, prior adoption behavior, and patient switching patterns. Analysis of low-propensity HCPs who nevertheless converted uncovered hidden opportunities and edge cases not captured by initial feature engineering, informing subsequent model refinements.</p>
        </div>
    </div>
</body>
</html>
